SectorPharmaceutical
Established Date--
Listing Date27/04/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees105
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressOne World Trade Center, Suite 8500, New York, New York 10007
Business
IntroductionDefinium Therapeutics, Inc., was incorporated in 2010 under the laws of British Columbia. They are a late-stage clinical biopharmaceutical company developing new product candidates to treat brain health disorders. Their mission is to forge a new era of psychiatry by applying the rigors of science to psychedelics, with the goal of developing available treatments to unlock healing at scale. They are developing a series of innovative product candidates targeting neurotransmitter pathways that play a key role in brain health diseases.
